当前位置: X-MOL 学术Lancet › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Exclusive and partial enteral nutrition for Crohn's disease
The Lancet ( IF 98.4 ) Pub Date : 2017-09-23 , DOI: 10.1016/s0140-6736(17)32392-9
Nizar H Senussi

In their Article, Subra Kugathasan and colleagues (April 29, p 1710)1 validated a risk-stratification model showing that early anti-tumour necrosis factor α therapy in patients with Crohn's disease was associated with reduced incidence of internal penetrating complications, although not stricturing complications.

中文翻译:

克罗恩病的独家和部分肠内营养

Subra Kugathasan及其同事(4月29日,第1710页)1在他们的文章中验证了一种风险分层模型,该模型表明克罗恩病患者早期抗肿瘤坏死因子α疗法与内部穿透并发症的发生率降低相关,尽管并没有严格限制。并发症。
更新日期:2017-09-21
down
wechat
bug